March 8, 2024 · Form 4 insider transaction
Wigzell Hans Lennart Rudolf sold 11,745 shares of Sarepta Therapeutics, Inc. at $123.10 per share, a transaction worth $1.45M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $122.65 to $123.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.